Dataset Information

NGLY1 mutation causes neuromotor impairment, intellectual disability, and neuropathy.

ABSTRACT: N-glycanase 1 (NGLY1) is a conserved enzyme that is responsible for the deglycosylation of misfolded N-glycosylated proteins in the cytoplasm prior to their proteasome-mediated degradation. Disruption of this degradation process has been associated with various neurologic diseases including amyotrophic lateral sclerosis and Parkinson's disease. Here, we describe two siblings with neuromotor impairment, apparent intellectual disability, corneal opacities, and neuropathy who were found to possess a novel homozygous frame-shift mutation due to a 4 base pair deletion in NGLY1 (c.1533_1536delTCAA, p.Asn511LysfsX51). We hypothesize that this mutation likely limits the capability of neuronal cells to respond to stress due to accumulation of misfolded proteins, thereby impairing their survival and resulting in progressive loss of neurological function.

SUBMITTER: Caglayan AO

PROVIDER: S-EPMC4804755 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

NGLY1 mutation causes neuromotor impairment, intellectual disability, and neuropathy.

Caglayan Ahmet Okay AO Comu Sinan S Baranoski Jacob F JF Parman Yesim Y Kaymakçalan Hande H Akgumus Gozde Tugce GT Caglar Caner C Dolen Duygu D Erson-Omay Emine Zeynep EZ Harmanci Akdes Serin AS Mishra-Gorur Ketu K Freeze Hudson H HH Yasuno Katsuhito K Bilguvar Kaya K Gunel Murat M

European journal of medical genetics 20140909 1

N-glycanase 1 (NGLY1) is a conserved enzyme that is responsible for the deglycosylation of misfolded N-glycosylated proteins in the cytoplasm prior to their proteasome-mediated degradation. Disruption of this degradation process has been associated with various neurologic diseases including amyotrophic lateral sclerosis and Parkinson's disease. Here, we describe two siblings with neuromotor impairment, apparent intellectual disability, corneal opacities, and neuropathy who were found to possess ...[more]

PMID: 25220016

Dataset Information

NGLY1 mutation causes neuromotor impairment, intellectual disability, and neuropathy.

Publications

NGLY1 mutation causes neuromotor impairment, intellectual disability, and neuropathy.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Similar Datasets

Homozygous ARHGEF2 mutation causes intellectual disability and midbrain-hindbrain malformation.
| S-EPMC5428974 | biostudies-literature

A novel UBE2A mutation causes X-linked intellectual disability type Nascimento.
| S-EPMC5462939 | biostudies-literature

Dominant <i>LMAN2L</i> mutation causes intellectual disability with remitting epilepsy.
| S-EPMC6469342 | biostudies-literature

Mutation in NSUN2, which encodes an RNA methyltransferase, causes autosomal-recessive intellectual disability.
| S-EPMC3376419 | biostudies-literature

A De Novo Mutation in DYRK1A Causes Syndromic Intellectual Disability: A Chinese Case Report.
| S-EPMC6877748 | biostudies-literature

DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies.
| S-EPMC4613469 | biostudies-literature

Novel NUDT2 variant causes intellectual disability and polyneuropathy.
| S-EPMC7664258 | biostudies-literature

A homozygous loss-of-function CAMK2A mutation causes growth delay, frequent seizures and severe intellectual disability.
| S-EPMC5963920 | biostudies-literature

NAA10 mutation causing a novel intellectual disability syndrome with Long QT due to N-terminal acetyltransferase impairment.
| S-EPMC4629191 | biostudies-literature

?IV Spectrinopathies Cause Profound Intellectual Disability, Congenital Hypotonia, and Motor Axonal Neuropathy.
| S-EPMC5992132 | biostudies-literature